Potential influence of interleukin-1 haplotype IL-1β-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: A case-control study

Human Immunology

Volumn 69, Issue 3, 2008, Pages 179-186

  Upadhyay, Rohit ^a   Jain, Meenu ^a   Kumar, Shaleen ^a   Ghoshal, Uday C ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Esophageal cancer; IL 1 haplotype; Interleukin 1

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1BETA;

ADULT; AGED; ALLELE; ARTICLE; CANCER LOCALIZATION; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; ESOPHAGUS CANCER; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HAPLOTYPE; HUMAN; INDIA; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VARIABLE NUMBER OF TANDEM REPEAT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INDIA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; MINISATELLITE REPEATS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 41549090373     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.01.012     Document Type: Article

References (33)

1. Smyth M.J., Cretney E., Kershaw M.H., and Hayakawa Y. Cytokines in cancer immunity and immunotherapy. Immunol Rev 202 (2004) 275
2. Apte R., and Voronov E. Interleukin 1: a major pleotropic cytokine in tumor-host interactions. Semin Cancer Biol 12 (2002) 277
3. Pantschenko A.G., Pushkar I., Anderson K.H., Wang Y., Miller L.J., Kurtzman S.H., et al. The interleukin-1 family of cytokines and receptors in human breast cancer: implications for tumor progression. Int J Oncol 23 (2003) 269
4. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., and Young H.A. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398
5. Macarthur M., Hold G.L., and El-Omar E.M. Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 286 (2004) G515
6. Steinkasserer A., Spurr N.K., Cox S., Jeggo P., and Sim R.B. The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14-q21, in the region of the IL-1 alpha and IL-1 beta loci. Genomics 13 (1992) 654
7. Bidwell J., Keen L., Gallagher G., Kimberly R., Huizinga T., and McDermott M.F. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1 (1999) 3
8. Figueiredo C., Machado J.C., Pharoah P., Seruca R., Sousa S., and Carvalho R. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 94 (2002) 1680
9. Machado J.C., Figueiredo C., Canedo P., Pharoah P., Carvalho R., Nabais S., et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125 (2003) 364
10. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095
11. Hu Z., Shao M., Chen Y., Zhou J., Qian J., Xu L., et al. Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer. Cancer Lett 236 (2006) 269
12. Vamvakopoulos J.E., Taylor C.J., Morris-Stiff G.J., Green C., and Metcalfe S. The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism. Eur J Immunogenet 29 (2002) 337
13. Arend W.P., and Gabay C. Physiologic role of interleukin-1 receptor antagonist. Arthritis Res 2 (2000) 245
14. Vamvakopoulos J., Green C., and Metcalfe S. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur J Immunol 32 (2002) 2988
15. Balasubramanian S.P., Azmy I.A., Higham S.E., Wilson A.G., Cross S.S., Cox A., et al. Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer 6 (2006) 188
16. Ito H., Kaneko K., Makino R., Konishi K., Kurahashi T., Yamamoto T., et al. Interleukin-1beta gene in esophageal, gastric and colorectal carcinomas. Oncol Rep 18 (2007) 473
17. Hurme M., and Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 28 (1998) 2598
18. Wilkinson R.J., Patel P., Llewelyn M., Hirch C.S., Pasvol G., Snounou G., et al. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med 189 (1999) 1863
19. Joos L., McIntyre L., Ruan J., Connett J.E., Anthonisen N.R., Weir T.D., et al. Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax 56 (2001) 863
20. Jain M., Kumar S., Rastogi N., Lal P., Ghoshal U.C., Tiwari A., et al. GSTT1, GSTM1 and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India. Cancer Lett 242 (2006) 60
21. Rad R., Prinz C., Neu B., Neuhofer M., Zeitner M., Voland P., et al. Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J Infect Dis 188 (2003) 272
22. Tarlow J.K., Blakemore A.I., Lennard A., Solari R., Hughes H.N., Steinkasserer A., et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91 (1993) 403
23. Schneider S., Roessli D., and Excoffier L. Arlequin ver. 2.00. Software for population genetics data analysis (2000), Genetics and Biometry Laboratory, University of Geneva, Switzerland
24. Hulkkonen J., Vilpo J., Vilpo L., Koski T., and Hurme M. Interleukin-1 beta, interleukin-1 receptor antagonist and interleukin-6 plasma levels and cytokine gene polymorphisms in chronic lymphocytic leukemia: correlation with prognostic parameters. Haematologica 85 (2000) 600
25. Kato S., Onda M., Yamada S., Matsuda N., Tokunaga A., and Matsukura N. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol 36 (2001) 696
26. Furuta T., El-Omar E.M., Xiao F., Shirai N., Takashima M., and Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 123 (2002) 92
27. Santtila S., Savinainen K., and Hurme M. Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47 (1998) 195
28. Hamajima N., Matsuo K., Saito T., Tajima K., Okuma K., Yamao K., et al. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res 92 (2001) 383
29. Ghoshal UC, Tiwari S, Dhingra S, Pandey R, Ghoshal U, Singh H. Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: The Indian enigma. Dig Dis Sci (In press).
30. Wu D.C., Wu I.C., Lee J.M., Hsu H.K., Kao E.L., Chou S.H., et al. Helicobacter pylori infection: a protective factor for esophageal squamous cell carcinoma in a Taiwanese population. Am J Gastroenetrology 100 (2005) 588
31. Straif K., Weiland S.K., Bungers M., Holthenrich D., Taeger D., Yi S., et al. Exposure to high concentrations of nitrosamines and cancer mortality among a cohort of rubber workers. Occup Environ Med 57 (2000) 180
32. Jain M., Kumar S., Ghoshal U.C., Tiwari A., and Mittal B. Role of GSTM3 polymorphism in the risk of developing esophageal cancer. Cancer Epidemiol Biomark Prev 16 (2007) 178
33. van Leeuwen D.M., van Agen E., Gottschalk R.W., Vlietinck R., Gielen M., van Herwijnen M.H., et al. Cigarette smoke-induced differential gene expression in blood cells from monozygotic twin pairs. Carcinogenesis 28 (2007) 691